BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2%
Mon, 28 Jan

BIOCON LTD has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

BIOCON LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m10,57913,21015,40816.6%45.6%
Other incomeRs m339544256-52.9%-24.5%
TurnoverRs m10,91813,75415,66413.9%43.5%
ExpensesRs m8,3629,81411,60118.2%38.7%
Gross profitRs m2,0005,2843,865-26.9%93.3%
DepreciationRs m9741,1221,1674.0%19.8%
InterestRs m147188186-1.1%26.5%
Profit before taxRs m1,2184,5182,768-38.7%127.3%
TaxRs m361732461-37.0%27.7%
Profit after taxRs m8573,7862,307-39.1%169.2%
Gross profit margin%18.940.025.1
Effective tax rate%29.616.216.7
Net profit margin%7.827.514.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 45.6% on a year-on-year (YoY) basis. The expenses were up by 38.7% YoY during the same period.
  • The company's operating profit increased by 93.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.1% in 3QFY19 as against 18.9% in 3QFY18.
  • Depreciation charges increased by 19.8% and finance costs increased by 26.5% YoY, respectively.
  • Other income declined by 24.5% YoY during the quarter.
  • Net profit for the quarter increased by 169.2% YoY. Net profit margins during the quarter increased from 7.8% in 3QFY18 to 14.7% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 16.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 18.2% QoQ during the same period.
  • The company's operating profit declined by 26.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 25.1% in 3QFY19 as against 40.0% in 2QFY18.
  • Net profit for the quarter declined by 39.1% QoQ, while net profit margins declined from 27.5% in 2QFY18 to 14.7% in 3QFY19.

To see how BIOCON LTD has performed over the last eight quarters, please visit here.

BIOCON LTD Share Price Performance

Over the last one year, BIOCON LTD share price has moved up from Rs 607.3 to Rs 647.7, registering a Gain of Rs 40.4 or around 6.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,707.8 (down 1.7%). Over the last one year it has moved down from 15,028.8 to 13,707.8, a gain of 1,321 points (down 8.8%).

Overall, the S&P BSE SENSEX is down 0.5% over the year.

Current Valuations

At the current price of Rs 647.7, the price to earnings (P/E) ratio of BIOCON LTD stands at 43.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.5 times.

Equitymaster requests your view! Post a comment on "BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2%". Click here!

  

Related Views on News

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Nov 20, 2019 (Close)

TRACK BIOCON

BIOCON - ADCOCK INGRAM COMPARISON

COMPARE BIOCON WITH

MARKET STATS